• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用自愿性公共卫生措施控制 2019 年冠状病毒病传播:以瑞典作为大流行控制的案例研究。

Managing Coronavirus Disease 2019 Spread With Voluntary Public Health Measures: Sweden as a Case Study for Pandemic Control.

机构信息

Science for Life Laboratory, Department of Chemistry-BMC, Uppsala University, Uppsala, Sweden.

Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.

出版信息

Clin Infect Dis. 2020 Dec 15;71(12):3174-3181. doi: 10.1093/cid/ciaa864.

DOI:10.1093/cid/ciaa864
PMID:32609825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7337695/
Abstract

BACKGROUND

The coronavirus disease 19 (COVID-19) pandemic has spread globally, causing extensive illness and mortality. In advance of effective antiviral therapies, countries have applied different public health strategies to control spread and manage healthcare need. Sweden has taken a unique approach of not implementing strict closures, instead urging personal responsibility. We analyze the results of this and other potential strategies for pandemic control in Sweden.

METHODS

We implemented individual-based modeling of COVID-19 spread in Sweden using population, employment, and household data. Epidemiological parameters for COVID-19 were validated on a limited date range; where substantial uncertainties remained, multiple parameters were tested. The effects of different public health strategies were tested over a 160-day period, analyzed for their effects on intensive care unit (ICU) demand and death rate, and compared with Swedish data for April 2020.

RESULTS

Swedish mortality rates are intermediate between rates for European countries that quickly imposed stringent public health controls and those for countries that acted later. Models most closely reproducing reported mortality data suggest that large portions of the population voluntarily self-isolate. Swedish ICU use rates remained lower than predicted, but a large fraction of deaths occurred in non-ICU patients. This suggests that patient prognosis was considered in ICU admission, reducing healthcare load at a cost of decreased survival in patients not admitted.

CONCLUSIONS

The Swedish COVID-19 strategy has thus far yielded a striking result: mild mandates overlaid with voluntary measures can achieve results highly similar to late-onset stringent mandates. However, this policy causes more healthcare demand and more deaths than early stringent control and depends on continued public will.

摘要

背景

新型冠状病毒病(COVID-19)大流行已在全球范围内蔓延,造成广泛的疾病和死亡。在有效的抗病毒疗法问世之前,各国已采取不同的公共卫生策略来控制传播并管理医疗保健需求。瑞典采取了独特的方法,没有实施严格的封锁,而是敦促个人承担责任。我们分析了这种方法和瑞典在大流行控制方面的其他潜在策略的结果。

方法

我们使用人口、就业和家庭数据对瑞典的 COVID-19 传播进行了基于个体的建模。针对 COVID-19 的流行病学参数在有限的日期范围内进行了验证;对于仍然存在大量不确定性的参数,我们进行了多次测试。在 160 天的时间内测试了不同的公共卫生策略的效果,分析了它们对重症监护病房(ICU)需求和死亡率的影响,并与瑞典 2020 年 4 月的数据进行了比较。

结果

瑞典的死亡率处于迅速实施严格公共卫生控制的欧洲国家和行动较晚的国家之间的死亡率之间。最能准确反映报告死亡率数据的模型表明,大部分人口都自愿自我隔离。瑞典的 ICU 使用率仍低于预测,但很大一部分死亡发生在非 ICU 患者中。这表明 ICU 入院考虑了患者的预后,降低了医疗保健负担,但未入院患者的生存率降低。

结论

迄今为止,瑞典的 COVID-19 策略取得了惊人的结果:轻度的强制措施与自愿措施相结合,可以取得与后期严格强制措施非常相似的结果。但是,这种政策会导致更多的医疗保健需求和更多的死亡,超过了早期严格控制的情况,并且取决于公众的持续意愿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/c8269ae543f0/ciaa864_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/6551553d1108/ciaa864_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/1df1d41f3611/ciaa864_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/92d230cbe334/ciaa864_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/f608465890e8/ciaa864_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/c8269ae543f0/ciaa864_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/6551553d1108/ciaa864_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/1df1d41f3611/ciaa864_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/92d230cbe334/ciaa864_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/f608465890e8/ciaa864_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5116/7819511/c8269ae543f0/ciaa864_fig5.jpg

相似文献

1
Managing Coronavirus Disease 2019 Spread With Voluntary Public Health Measures: Sweden as a Case Study for Pandemic Control.用自愿性公共卫生措施控制 2019 年冠状病毒病传播:以瑞典作为大流行控制的案例研究。
Clin Infect Dis. 2020 Dec 15;71(12):3174-3181. doi: 10.1093/cid/ciaa864.
2
Leveraging epidemiological principles to evaluate Sweden's COVID-19 response.利用流行病学原理评估瑞典的 COVID-19 应对措施。
Ann Epidemiol. 2021 Feb;54:21-26. doi: 10.1016/j.annepidem.2020.11.005. Epub 2020 Nov 23.
3
COVID-19 healthcare demand and mortality in Sweden in response to non-pharmaceutical mitigation and suppression scenarios.瑞典针对非药物缓解和抑制情景的 COVID-19 医疗需求和死亡率。
Int J Epidemiol. 2020 Oct 1;49(5):1443-1453. doi: 10.1093/ije/dyaa121.
4
Public health, surveillance policies and actions to prevent community spread of COVID-19 in Denmark, Serbia and Sweden.丹麦、塞尔维亚和瑞典的公共卫生、监测政策和行动,以预防 COVID-19 在社区的传播。
Scand J Public Health. 2022 Aug;50(6):711-729. doi: 10.1177/14034948211056215. Epub 2021 Nov 29.
5
Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.评估 2020 年 1 月 1 日至 2022 年 7 月 31 日美国各州的 COVID-19 大流行政策和行为及其经济和教育方面的权衡取舍:一项观察性分析。
Lancet. 2023 Apr 22;401(10385):1341-1360. doi: 10.1016/S0140-6736(23)00461-0. Epub 2023 Mar 23.
6
The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.新冠病毒严重感染高风险的5%人群是可识别的,在经济重启时需要予以考虑。
J Psychiatr Pract. 2020 May;26(3):219-227. doi: 10.1097/PRA.0000000000000475.
7
Implementation of a broad public health approach to COVID-19 in Sweden, January 2020 to May 2022.2020 年 1 月至 2022 年 5 月期间瑞典对 COVID-19 实施广泛的公共卫生措施。
Euro Surveill. 2023 Oct;28(41). doi: 10.2807/1560-7917.ES.2023.28.41.2300063.
8
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
9
Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.封锁对欧洲和北美 7 个国家的新冠病毒病死率和病毒突变传播的影响。
J Transl Med. 2020 Sep 2;18(1):338. doi: 10.1186/s12967-020-02501-x.
10
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.

引用本文的文献

1
What Lessons can Be Learned From the Management of the COVID-19 Pandemic?从新冠疫情管理中可以吸取哪些教训?
Int J Public Health. 2025 May 30;70:1607727. doi: 10.3389/ijph.2025.1607727. eCollection 2025.
2
Back to Basics: The Diagnostic Value of a Complete Blood Count in the Clinical Management of COVID-19.回归基础:全血细胞计数在新型冠状病毒肺炎临床管理中的诊断价值
Diagnostics (Basel). 2024 Sep 2;14(17):1933. doi: 10.3390/diagnostics14171933.
3
Integrated Surveillance of Disparities in Vaccination Coverage and Morbidity during the COVID-19 Pandemic: A Cohort Study in Southeast Sweden.

本文引用的文献

1
Challenges in control of COVID-19: short doubling time and long delay to effect of interventions.控制 COVID-19 的挑战:短的倍增时间和干预效果的长延迟。
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200264. doi: 10.1098/rstb.2020.0264. Epub 2021 May 31.
2
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany.德国超级传播事件中 SARS-CoV2 的感染病死率。
Nat Commun. 2020 Nov 17;11(1):5829. doi: 10.1038/s41467-020-19509-y.
3
The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries.
新冠疫情期间疫苗接种覆盖率和发病率差异的综合监测:瑞典东南部的一项队列研究
Vaccines (Basel). 2024 Jul 12;12(7):763. doi: 10.3390/vaccines12070763.
4
Exploring the working life of people with multiple sclerosis during the COVID-19 pandemic in Sweden.探索 COVID-19 大流行期间瑞典多发性硬化症患者的工作生活。
BMC Public Health. 2024 May 23;24(1):1389. doi: 10.1186/s12889-024-18844-9.
5
Coronavirus disease 2019 infection among working-aged people with multiple sclerosis and the impact of disease-modifying therapies.多发性硬化症工作年龄人群中的2019冠状病毒病感染及疾病修正治疗的影响
Mult Scler J Exp Transl Clin. 2024 Apr 27;10(2):20552173241248293. doi: 10.1177/20552173241248293. eCollection 2024 Apr-Jun.
6
Model uncertainty, the COVID-19 pandemic, and the science-policy interface.模型的不确定性、新冠疫情与科学-政策界面
R Soc Open Sci. 2024 Feb 14;11(2):230803. doi: 10.1098/rsos.230803. eCollection 2024 Feb.
7
Associations between the spread of COVID-19 and end-of-life circumstances in the non-infected population of Sweden.瑞典未感染人群中新冠病毒病传播与临终情况之间的关联。
Scand J Public Health. 2024 May;52(3):290-298. doi: 10.1177/14034948231216197. Epub 2023 Dec 28.
8
Design and Evaluation of an Intensive Care Unit Dashboard Built in Response to the COVID-19 Pandemic: Semistructured Interview Study.针对新冠疫情设计并评估重症监护病房信息平台:半结构化访谈研究
JMIR Hum Factors. 2023 Sep 26;10:e49438. doi: 10.2196/49438.
9
The risk for celiac disease after Covid-19 infection.新冠病毒感染后患乳糜泻的风险。
BMC Gastroenterol. 2023 May 22;23(1):174. doi: 10.1186/s12876-023-02795-3.
10
How did the German and other European electricity systems react to the COVID-19 pandemic?德国和其他欧洲电力系统对新冠疫情作何反应?
Appl Energy. 2021 Mar 1;285:116370. doi: 10.1016/j.apenergy.2020.116370. Epub 2021 Jan 6.
新冠疫情的影响以及中低收入国家的缓解和抑制策略。
Science. 2020 Jul 24;369(6502):413-422. doi: 10.1126/science.abc0035. Epub 2020 Jun 12.
4
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.估算非药物干预措施对欧洲 COVID-19 疫情的影响。
Nature. 2020 Aug;584(7820):257-261. doi: 10.1038/s41586-020-2405-7. Epub 2020 Jun 8.
5
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.预测 SARS-CoV-2 的传播动力学,直至大流行后期。
Science. 2020 May 22;368(6493):860-868. doi: 10.1126/science.abb5793. Epub 2020 Apr 14.
6
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.从中国武汉的传播动态估计 COVID-19 的临床严重程度。
Nat Med. 2020 Apr;26(4):506-510. doi: 10.1038/s41591-020-0822-7. Epub 2020 Mar 19.
7
Special report: The simulations driving the world's response to COVID-19.特别报道:推动全球应对新冠疫情的模拟分析
Nature. 2020 Apr;580(7803):316-318. doi: 10.1038/d41586-020-01003-6.
8
Estimates of the severity of coronavirus disease 2019: a model-based analysis.新型冠状病毒疾病 2019 严重程度的估计:基于模型的分析。
Lancet Infect Dis. 2020 Jun;20(6):669-677. doi: 10.1016/S1473-3099(20)30243-7. Epub 2020 Mar 30.
9
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.
10
Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.利用 2020 年 2 月钻石公主号游轮上疫情的年龄调整后数据估计冠状病毒病(COVID-19)的感染和病死率。
Euro Surveill. 2020 Mar;25(12). doi: 10.2807/1560-7917.ES.2020.25.12.2000256.